Literature DB >> 21087736

Accurate prevalence and uptake of testing for Huntington's disease.

Patrick J Morrison1.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21087736     DOI： 10.1016/S1474-4422(10)70287-8

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  10 in total

Review 1.  Ethics and neuropsychiatric genetics: a review of major issues.

Authors:  Steven K Hoge; Paul S Appelbaum
Journal:  Int J Neuropsychopharmacol       Date:  2012-01-25       Impact factor: 5.176

Review 2.  'The clocks that time us'--circadian rhythms in neurodegenerative disorders.

Authors:  Aleksandar Videnovic; Alpar S Lazar; Roger A Barker; Sebastiaan Overeem
Journal:  Nat Rev Neurol       Date:  2014-11-11       Impact factor: 42.937

3.  A network diffusion model of disease progression in dementia.

Authors:  Ashish Raj; Amy Kuceyeski; Michael Weiner
Journal:  Neuron       Date:  2012-03-21       Impact factor: 17.173

4.  Analysis of the Reasons for Non-Uptake of Predictive Testing for Huntington's Disease in Spain: A Qualitative Study.

Authors:  Jesús Rivera-Navarro; Esther Cubo; Natividad Mariscal
Journal:  J Genet Couns       Date:  2015-04-30       Impact factor: 2.537

Review 5.  Circadian rhythms in neurodegenerative disorders.

Authors:  Malik Nassan; Aleksandar Videnovic
Journal:  Nat Rev Neurol       Date:  2021-11-10       Impact factor: 42.937

Review 6.  Consequences of Circadian Disruption on Neurologic Health.

Authors:  Aleksandar Videnovic; Phyllis C Zee
Journal:  Sleep Med Clin       Date:  2015-09-26

Review 7.  Novel targets for Huntington's disease: future prospects.

Authors:  Sarah L Mason; Roger A Barker
Journal:  Degener Neurol Neuromuscul Dis       Date:  2016-05-04

8.  Sleep deficits but no metabolic deficits in premanifest Huntington's disease.

Authors:  Alpar S Lazar; Francesca Panin; Anna O G Goodman; Stanley E Lazic; Zsolt I Lazar; Sarah L Mason; Lorraine Rogers; Peter R Murgatroyd; Laura P E Watson; Priya Singh; Beth Borowsky; John M Shneerson; Roger A Barker
Journal:  Ann Neurol       Date:  2015-08-21       Impact factor: 10.422

Review 9.  Theranostic applications of nanoparticles in neurodegenerative disorders.

Authors:  Sahana Ramanathan; Govindaraju Archunan; Muthusamy Sivakumar; Subramanian Tamil Selvan; A Lenin Fred; Sundramurthy Kumar; Balázs Gulyás; Parasuraman Padmanabhan
Journal:  Int J Nanomedicine       Date:  2018-09-20

10.  Prevalence of adult Huntington's disease in the UK based on diagnoses recorded in general practice records.

Authors:  Stephen J W Evans; Ian Douglas; Michael D Rawlins; Nancy S Wexler; Sarah J Tabrizi; Liam Smeeth
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-03-12       Impact factor: 10.154
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.